Abstract
<p style='text-indent:20px;'>We investigate a mathematical model of tumor–immune system interactions with oncolytic virus therapy (OVT). Susceptible tumor cells may become infected by viruses that are engineered specifically to kill cancer cells but not healthy cells. Once the infected cancer cells are destroyed by oncolysis, they release new infectious virus particles to help kill surrounding tumor cells. The immune system constructed includes innate and adaptive immunities while the adaptive immunity is further separated into anti-viral or anti-tumor immune cells. The model is first analyzed by studying boundary equilibria and their stability. Numerical bifurcation analysis is performed to investigate the outcomes of the oncolytic virus therapy. The model has a unique tumor remission equilibrium, which is unlikely to be stable based on the parameter values given in the literature. Multiple stable positive equilibria with tumor sizes close to the carrying capacity coexist in the system if the tumor is less antigenic. However, as the viral infection rate increases, the OVT becomes more effective in the sense that the tumor can be dormant for a longer period of time even when the tumor is weakly antigenic.</p>
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.